Throughout the last three months, 7 analysts have evaluated Hinge Health (NYSE:HNGE), offering a diverse set of opinions from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Analysts have recently evaluated Hinge Health and provided 12-month price targets. The average target is $62.14, accompanied by a high estimate of $70.00 and a low estimate of $59.00. Highlighting a 4.69% decrease, the current average has fallen from the previous average price target of $65.20.

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Hinge Health. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hinge Health. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Hinge Health compared to the broader market.
• Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Hinge Health's stock. This comparison reveals trends in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Hinge Health's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Hinge Health analyst ratings.

All You Need to Know About Hinge Health

Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.

Hinge Health: Financial Performance Dissected

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Hinge Health's remarkable performance in 3M is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of 53.27%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -1.2%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Hinge Health's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -0.97%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): Hinge Health's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.25%, the company may face hurdles in achieving optimal financial returns.

Debt Management: Hinge Health's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Core of Analyst Ratings: What Every Investor Should Know

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

This article was generated by Benzinga's automated content engine and reviewed by an editor.